Ditchcarbon
  • Customers
  1. Organizations
  2. KALA BIO, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

KALA BIO, Inc.

Company website

KALA BIO, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for patients with serious diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the realm of gene therapy and precision medicine. KALA BIO's core offerings include advanced gene delivery systems designed to enhance therapeutic efficacy and safety. Their unique approach leverages proprietary technology to address unmet medical needs, setting them apart in a competitive market. With a commitment to scientific excellence, KALA BIO has achieved significant milestones, positioning itself as a leader in the development of transformative treatments. The company continues to expand its operational footprint, aiming to make a lasting impact on patient care globally.

DitchCarbon Score

How does KALA BIO, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

KALA BIO, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

KALA BIO, Inc.'s reported carbon emissions

KALA BIO, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that KALA BIO, Inc. may not have established formal climate initiatives or targets at this time. As the company operates within the biopharmaceutical industry, it is essential for them to consider developing a comprehensive climate strategy to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. KALA BIO, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for KALA BIO, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

KALA BIO, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Nova Eye Medical Limited

AU
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 14 days ago

New World Medical, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 14 days ago

Oyster Point Pharma, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Sun Pharmaceutical Industries Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Aerie Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.9
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy